The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Underlying Medical Conditions Associated With Severe COVID-19 Illness Among Children
Open accessAbstract
Importance: Information on underlying conditions and severe COVID-19 illness among children is limited. Objective: To examine the risk of severe COVID-19 illness among children associated with underlying medical conditions and medical complexity. Design, Setting, and Participants: This cross-sectional study included patients aged 18 years and younger with International Statistical Classification of Diseases, Tenth Revision, Clinical Modification code U07.1 (COVID-19) or B97.29 (other coronavirus) during an emergency department or inpatient encounter from March 2020 through January 2021. Data were collected from the Premier Healthcare Database Special COVID-19 Release, which included data from more than 800 US hospitals. Multivariable generalized linear models, controlling for patient and hospital characteristics, were used to estimate adjusted risk of severe COVID-19 illness associated with underlying medical conditions and medical complexity. Exposures: Underlying medical conditions and medical complexity (ie, presence of complex or noncomplex chronic disease). Main Outcomes and Measures: Hospitalization and severe illness when hospitalized (ie, combined outcome of intensive care unit admission, invasive mechanical ventilation, or death). Results: Among 43 465 patients with COVID-19 aged 18 years or younger, the median (interquartile range) age was 12 (4-16) years, 22 943 (52.8%) were female patients, and 12 491 (28.7%) had underlying medical conditions. The most common diagnosed conditions were asthma (4416 [10.2%]), neurodevelopmental disorders (1690 [3.9%]), anxiety and fear-related disorders (1374 [3.2%]), depressive disorders (1209 [2.8%]), and obesity (1071 [2.5%]). The strongest risk factors for hospitalization were type 1 diabetes (adjusted risk ratio [aRR], 4.60; 95% CI, 3.91-5.42) and obesity (aRR, 3.07; 95% CI, 2.66-3.54), and the strongest risk factors for severe COVID-19 illness were type 1 diabetes (aRR, 2.38; 95% CI, 2.06-2.76) and cardiac and circulatory congenital anomalies (aRR, 1.72; 95% CI, 1.48-1.99). Prematurity was a risk factor for severe COVID-19 illness among children younger than 2 years (aRR, 1.83; 95% CI, 1.47-2.29). Chronic and complex chronic disease were risk factors for hospitalization, with aRRs of 2.91 (95% CI, 2.63-3.23) and 7.86 (95% CI, 6.91-8.95), respectively, as well as for severe COVID-19 illness, with aRRs of 1.95 (95% CI, 1.69-2.26) and 2.86 (95% CI, 2.47-3.32), respectively. Conclusions and Relevance: This cross-sectional study found a higher risk of severe COVID-19 illness among children with medical complexity and certain underlying conditions, such as type 1 diabetes, cardiac and circulatory congenital anomalies, and obesity. Health care practitioners could consider the potential need for close observation and cautious clinical management of children with these conditions and COVID-19.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity
White, H. (1980) · Econometrica · doi:10.2307/1912934 · Cited by 25,861
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040296 · Cited by 23,020
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-8-200710160-00010 · Cited by 17,796
A Modified Poisson Regression Approach to Prospective Studies with Binary Data
Zou, G. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh090 · Cited by 9,615
Prevalence of Obesity Among Adults and Youth: United States, 2015-2016.
Hales, C. M., Carroll, M. D., Fryar, C. D., & Ogden, C. L. (2017) · PubMed · Cited by 3,884
An overview of mortality and sequelae of preterm birth from infancy to adulthood
Saigal, S., & Doyle, L. W. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60136-1 · Cited by 2,818
COVID-19 and its implications for thrombosis and anticoagulation
Connors, J. M., & Levy, J. H. (2020) · Blood · doi:10.1182/blood.2020006000 · Cited by 2,369
Easy SAS Calculations for Risk or Prevalence Ratios and Differences
Spiegelman, D. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi188 · Cited by 1,738
COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study
Götzinger, F., Santiago-García, B., Noguera-Julián, A., Lanaspa, M., Lancella, L., Calò Carducci, F. I., Gabrovska, N., Velizarova, S., Prunk, P., Osterman, V., et al. (2020) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(20)30177-2 · Cited by 1,219
Well-being of parents and children during the COVID-19 pandemic: A national survey
Patrick, S. W., Henkhaus, L. E., Zickafoose, J. S., Lovell, K., Halvorson, A., Loch, S., Letterie, M., & Davis, M. M. (2020) · Pediatrics · doi:10.1542/peds.2020-016824 · Cited by 1,200
Shekerdemian, L. S., Mahmood, N. R., Wolfe, K. K., Riggs, B. J., Ross, C. E., McKiernan, C. A., Heidemann, S. M., Kleinman, L. C., Sen, A. I., Hall, M. W., et al. (2020) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2020.1948 · Cited by 985
Barron, E., Bakhai, C., Kar, P., Weaver, A., Bradley, D., Ismail, H., Knighton, P., Holman, N., Khunti, K., Sattar, N., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30272-2 · Cited by 945
Dynamics of Obesity and Chronic Health Conditions Among Children and Youth
Van Cleave, J. (2010) · JAMA · doi:10.1001/jama.2010.104 · Cited by 693
Tartof, S. Y., Qian, L., Hong, V., Wei, R., Nadjafi, R. F., Fischer, H., Li, Z., Shaw, S. F., Caparosa, S. L., Nau, C. L., et al. (2020) · Annals of Internal Medicine · doi:10.7326/m20-3742 · Cited by 608
Leeb, R. T., Bitsko, R. H., Radhakrishnan, L., Martinez, P., Njai, R., & Holland, K. M. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6945a3 · Cited by 557
Kim, L., Whitaker, M., O’Halloran, A., Kambhampati, A., Chai, S. J., Reingold, A., Armistead, I., Kawasaki, B., Meek, J., Yousey-Hindes, K., et al. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6932e3 · Cited by 513
Zachariah, P., Johnson, C. L., Halabi, K. C., Ahn, D., Sen, A. I., Fischer, A., Banker, S. L., Giordano, M., Manice, C. S., Diamond, R., et al. (2020) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2020.2430 · Cited by 511
Zhao, Q., Meng, M., Kumar, R., Wu, Y., Huang, J., Deng, Y., Weng, Z., & Yang, L. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.04.086 · Cited by 502
Risk Factors for Venous Thromboembolism
Goldhaber, S. Z. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.01.057 · Cited by 383
Severe COVID-19 Infection and Pediatric Comorbidities: A Systematic Review and Meta-Analysis
Tsankov, B. K., Allaire, J. M., Irvine, M. A., Lopez, A. A., Sauvé, L. J., Vallance, B. A., & Jacobson, K. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.11.163 · Cited by 370
Kamrath, C., Mönkemöller, K., Biester, T., Rohrer, T. R., Warncke, K., Hammersen, J., & Holl, R. W. (2020) · JAMA · doi:10.1001/jama.2020.13445 · Cited by 310
Risk Factors for Severe COVID-19 in Children
Graff, K., Smith, C., Silveira, L., Jung, S., Curran-Hays, S., Jarjour, J., Carpenter, L., Pickard, K., Mattiucci, M., Fresia, J., et al. (2021) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000003043 · Cited by 278
COVID-19 Disease Severity Risk Factors for Pediatric Patients in Italy
Bellino, S., Punzo, O., Rota, M. C., Del Manso, M., Urdiales, A. M., Andrianou, X., Fabiani, M., Boros, S., Vescio, F., Riccardo, F., et al. (2020) · Pediatrics · doi:10.1542/peds.2020-009399 · Cited by 236
Development and Validation of the Pediatric Medical Complexity Algorithm (PMCA) Version 3.0
Simon, T. D., Haaland, W., Hawley, K., Lambka, K., & Mangione-Smith, R. (2018) · Academic Pediatrics · doi:10.1016/j.acap.2018.02.010 · Cited by 233
COVID-19 and obesity in childhood and adolescence: a clinical review
Nogueira-de-Almeida, C. A., Del Ciampo, L. A., Ferraz, I. S., Del Ciampo, I. R. L., Contini, A. A., & Ued, F. D. V. (2020) · Jornal de Pediatria · doi:10.1016/j.jped.2020.07.001 · Cited by 233
Has COVID-19 Delayed the Diagnosis and Worsened the Presentation of Type 1 Diabetes in Children?
Rabbone, I., Schiaffini, R., Cherubini, V., Maffeis, C., Scaramuzza, A., Diabetes Study Group of the Italian Society for Pediatric Endocrinology and Diabetes, Bertelli, E., Ferlito, L., Bobbio, A., Schieven, E., et al. (2020) · Diabetes Care · doi:10.2337/dc20-1321 · Cited by 218
Impact of lockdown in COVID 19 on glycemic control in patients with type 1 Diabetes Mellitus
Verma, A., Rajput, R., Verma, S., Balania, V. K. B., & Jangra, B. (2020) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2020.07.016 · Cited by 192
Uptake and Accuracy of the Diagnosis Code for COVID-19 Among US Hospitalizations
Kadri, S. S., Gundrum, J., Warner, S., Cao, Z., Babiker, A., Klompas, M., & Rosenthal, N. (2020) · JAMA · doi:10.1001/jama.2020.20323 · Cited by 185
Hypocalcemia is highly prevalent and predicts hospitalization in patients with COVID-19
Di Filippo, L., Formenti, A. M., Rovere-Querini, P., Carlucci, M., Conte, C., Ciceri, F., Zangrillo, A., & Giustina, A. (2020) · Endocrine · doi:10.1007/s12020-020-02383-5 · Cited by 182
Singh, A. K., & Singh, R. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108382 · Cited by 180
Prognostic Value of Leukocytosis and Lymphopenia for Coronavirus Disease Severity
Huang, G., Kovalic, A. J., & Graber, C. J. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2608.201160 · Cited by 167
Body mass index and outcome in patients with COVID-19: A dose–response meta-analysis
Pranata, R., Lim, M. A., Yonas, E., Vania, R., Lukito, A. A., Siswanto, B. B., & Meyer, M. (2021) · Diabetes & Metabolism · doi:10.1016/j.diabet.2020.07.005 · Cited by 163
Arah, O. A. (2008) · Emerging Themes in Epidemiology · doi:10.1186/1742-7622-5-5 · Cited by 162
SARS-CoV-2–Associated Deaths Among Persons Aged <21 Years — United States, February 12–July 31, 2020
Bixler, D., Miller, A. D., Mattison, C. P., Taylor, B., Komatsu, K. K., Pompa, X. P., Moon, S., Karmarkar, E. N., Liu, C. Y., Openshaw, J. J., et al. (2020) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6937e4 · Cited by 151
Asthma among hospitalized patients with COVID-19 and related outcomes
Lovinsky‐Desir, S., Deshpande, D., De, A., Murray, L. P., Stingone, J. A., Chan, A., Patel, N. N., Rai, N., DiMango, E., Milner, J. D., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.07.026 · Cited by 137
Births in the United States, 2018.
Martin, J. A., Hamilton, B. E., & Osterman, M. J. K. (2019) · PubMed · Cited by 134
Prevalence and predictive value of hypocalcemia in severe COVID-19 patients
Liu, J., Han, P., Wu, J., Gong, J., & Tian, D. (2020) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2020.05.029 · Cited by 130
Alsaied, T., Aboulhosn, J., Cotts, T. B., Daniels, C. J., Etheridge, S. P., Feltes, T. F., Gurvitz, M. Z., Lewin, M., Oster, M. E., & Saidi, A. S. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.017224 · Cited by 129
Incidence and case fatality rate of COVID-19 in patients with active epilepsy
Cabezudo‐García, P., Ciano-Petersen, N. L., Vázquez, N. M., Pons-Pons, G., Castro-Sánchez, M. V., & Serrano-Castro, P. J. (2020) · Neurology · doi:10.1212/wnl.0000000000010033 · Cited by 96
Chang, T., Chou, C., & Chang, L. (2020) · Obesity Reviews · doi:10.1111/obr.13089 · Cited by 69
Coronavirus Disease 2019 Infection in Children with Pre-Existing Heart Disease
Simpson, M., Collins, C., Nash, D. B., Panesar, L. E., & Oster, M. E. (2020) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2020.07.069 · Cited by 32
Basatemür, E., Jones, A., Peters, M. J., & Ramnarayan, P. (2020) · Archives of Disease in Childhood · doi:10.1136/archdischild-2020-320471 · Cited by 27
Wells, B. J., Lenoir, K. M., Wagenknecht, L. E., Mayer‐Davis, E. J., Lawrence, J. M., Dabelea, D., Pihoker, C., Saydah, S., Casanova, R., Turley, C. B., et al. (2020) · Diabetes Care · doi:10.2337/dc20-0063 · Cited by 22
Borgmeyer, A. E., Ercole, P. M., Niesen, A., & Strunk, R. C. (2016) · Hospital Pediatrics · doi:10.1542/hpeds.2015-0242 · Cited by 14
Cited by
Lister, N. B., Baur, L. A., Felix, J. F., Hill, A. J., Marcus, C., Reinehr, T., Summerbell, C., & Wabitsch, M. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00435-4 · Cited by 500
Risk Factors for Severe COVID-19 in Children
Woodruff, R. C., Campbell, A. P., Taylor, C. A., Chai, S. J., Kawasaki, B., Meek, J., Anderson, E. J., Weigel, A., Monroe, M. L., Reeg, L., et al. (2022) · Pediatrics · doi:10.1542/peds.2021-053418 · Cited by 268
Siegel, D. A., Reses, H. E., Cool, A. J., Shapiro, C. N., Hsu, J., Boehmer, T. K., Cornwell, C. R., Gray, E. B., Henley, S. J., Lochner, K., et al. (2021) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7036e1 · Cited by 147
Self-citationBahl, A., Mielke, N., Johnson, S., Desai, A., & Qu, L. (2023) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2022.100405 · Cited by 76
Metadata
- Authors
- Kompaniyets, L., Agathis, N. T., Nelson, J. M., Preston, L. E., Ko, J. Y., Belay, B., Pennington, A. F., Danielson, M. L., DeSisto, C. L., Chevinsky, J. R., Schieber, L. Z., Yusuf, H., Baggs, J., Mac Kenzie, W. R., Wong, K. K., Boehmer, T. K., Gundlapalli, A. V., & Goodman, A. B.
- Venue
- JAMA Network Open
- Publisher
- American Medical Association (AMA)
- Published
- 2021-06-07
- Volume
- 4
- Issue
- 6
- Pages
- e2111182
- ISSN
- 2574-3805 (ISSN-L)
- OpenAlex
- W3173119869
- Cited by
- 401
- References
- 44
- FWCI
- 25.54
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.